↓ Skip to main content

Dove Medical Press

Article Metrics

Bronchodilators use in patients with COPD

Overview of attention for article published in International Journal of Chronic Obstructive Pulmonary Disease, September 2015
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (64th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (58th percentile)

Mentioned by

twitter
6 tweeters

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
42 Mendeley
Title
Bronchodilators use in patients with COPD
Published in
International Journal of Chronic Obstructive Pulmonary Disease, September 2015
DOI 10.2147/copd.s86198
Pubmed ID
Authors

Chia-Lin Hsu, Yaa-Hui Dong, Ying-Ying Li, Chia-Hsuin Chang, Mei-Shu Lai

Abstract

Bronchodilators are commonly used as maintenance and rescue therapy in patients with COPD. We aimed to examine the prescribing patterns of bronchodilators in clinical practice. We identified patients with COPD who initiated oral or inhaled bronchodilators between 2001 and 2010 from the Taiwan National Health Insurance Research Database. We followed the patients for 1 year. For bronchodilator prescriptions, we classified the treatments based on medication classes and regimens (oral bronchodilators alone, oral and inhaled bronchodilators in combination, or inhaled bronchodilators alone). For inhaled bronchodilator prescriptions, we further classified the treatments as short-acting bronchodilators alone, short-acting and long-acting bronchodilators in combination, and long-acting bronchodilators alone. We evaluated the prescribing patterns and the change with time, in different physician specialists, and in different hospital accreditation levels. Among a cohort of 4,387 study-eligible patients, we identified 21,235 bronchodilator prescriptions for the analysis. The majority of prescriptions were oral xanthines or beta-2 agonists (62.63% and 47.54%, respectively) rather than prescriptions for inhaled bronchodilators (less than 10%). Nearly 80% of prescriptions were oral bronchodilator alone regimens. Use of oral bronchodilators declined with time and varied with health care providers, which were most commonly prescribed by non-chest specialists and in primary care clinics. Despite limited use of inhaled bronchodilators, it was noted that short-acting bronchodilators alone regimens accounted for 60% of the inhaled bronchodilator prescriptions. Excessive use of oral and short-acting bronchodilators is noted in general practice. Further research and education programs are warranted to decrease inadequate oral bronchodilators and optimize inhaled treatments in the management of patients with COPD.

Twitter Demographics

The data shown below were collected from the profiles of 6 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 42 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Australia 1 2%
Unknown 41 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 12 29%
Student > Bachelor 7 17%
Researcher 5 12%
Other 4 10%
Student > Ph. D. Student 4 10%
Other 4 10%
Unknown 6 14%
Readers by discipline Count As %
Medicine and Dentistry 17 40%
Pharmacology, Toxicology and Pharmaceutical Science 5 12%
Nursing and Health Professions 5 12%
Immunology and Microbiology 2 5%
Engineering 2 5%
Other 5 12%
Unknown 6 14%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 September 2015.
All research outputs
#7,169,294
of 14,159,686 outputs
Outputs from International Journal of Chronic Obstructive Pulmonary Disease
#729
of 1,748 outputs
Outputs of similar age
#83,186
of 239,542 outputs
Outputs of similar age from International Journal of Chronic Obstructive Pulmonary Disease
#37
of 90 outputs
Altmetric has tracked 14,159,686 research outputs across all sources so far. This one is in the 49th percentile – i.e., 49% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,748 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.3. This one has gotten more attention than average, scoring higher than 57% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 239,542 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.
We're also able to compare this research output to 90 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 58% of its contemporaries.